Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (5): 559-563.doi: 10.3736/jcim20070517

• Original Experimental Research • Previous Articles     Next Articles

Effects of melittin on expressions of mitochondria membrane protein 7A6, cell apoptosis-related gene products Fas and Fas Ligand in hepatocarcinoma cells

Chen Zhang, Bai Li, Shu-qin Lu, Yong Li, Yong-hua Su, Chang-quan Ling   

  1. Department of T raditional Chinese Medicine ,Changhai Hospital ,Second Military Medical University , Shanghai 200433 ,China
  • Online:2007-09-20 Published:2007-09-15

Objective: To observe the effects of melittin on the expressions of mitochondria membrane protein 7A6, cell apoptosis-related gene products Fas and Fas ligand (FasL) in hepatocarcinoma cells in vitro and to study the mechanisms of melittin in inducing apoptosis of hepatocarcinoma cells.Methods: BEL-7402 cell line was treated with melittin in vitro. The expressions of mitochondria membrane protein 7A6, cell apoptosis-related gene products Fas and FasL were detected by flow cytometry. Fas and FasL mRNAs were analyzed by reverse transcription polymerase chain reaction (RT-PCR) assay.Results: The expression rates of mitochondria membrane protein 7A6 of BEL-7402 hepatocarcinoma cells in 8, 16, 32 μg/ml melittin-treated and control groups were 4.89%, 17.74%, 11.45% and 1.02%, respectively. The expression of Fas protein was up-regulated by melittin, while FasL expression did not change. RT-PCR results showed that Fas mRNA expression was up-regulated by 32 μg/ml melittin and FasL mRNA expression was not observed.Conclusion: The effects of melittin in inducing hepatocarcinoma cell apoptosis may be related with up-regulating the expressions of mitochondria membrane protein 7A6 and Fas protein.

Key words: melittin, liver cancer, mitochondrial proteins, Fas antigens

CLC Number: 

  • R735.7

Figure 1

Effect of melittin on expression of 7A6 protein of BEL-7402 cellsA: Isotype; B: Control group; C: 8 μg/ml melittin-treated group; D: 16 μg/ml melittin-treated group; E: 32 μg/ml melittin-treated group."

Figure 2

Effects of melittin on expressions of Fas protein and FasL of BEL-7402 cellsn=4; *P<0.05, **P<0.01, vs control group."

Table 1

Fas mRNA expression in BEL-7402 cells treated with different concentrations of melittin (ヌ±S)"

Group Fas β-actin Ratio
Control 207.67±11.52 176.33±10.59 1.17±0.13
8 μg/ml melittin-treated 172.00±12.42 158.67±10.53 1.10±0.19
16 μg/ml melittin-treated 176.00±12.42 158.10±10.52 1.19±0.17
32 μg/ml melittin-treated 170.67±6.11 147.00±9.53 1.36±0.13*

Figure 3

Electropherogram of Fas mRNAA: β-actin; B: Fas; M: Marker; C: Control group; 1: 8 μg/ml melittin-treated group; 2: 16 μg/ml melittin-treated group; 3: 32 μg/ml melittin-treated group."

Figure 4

Electropherogram of FasL mRNAA: β-actin; B: FasL; M: Marker; C: Control group; 1: 8 μg/ml melittin-treated group; 2: 16 μg/ml melittin-treated group; 3: 32 μg/ml melittin-treated group."

[1] 张晨, 万旭英, 李柏 , 等. 蜂毒素对肝癌细胞系BEL-7402细胞凋亡的影响[J]. 安徽中医学院学报, 2003,22(4):44-46
Zhang C, Wan XY, Li B , et al. Effect of melittin on apoptosis of hepatocarcinoma cell line BEL-7402[J]. Anhui Zhong Yi Xue Yuan Xue Bao, 2003,22(4):44-46
[2] 李柏, 凌昌全, 张晨 , 等. 蜂毒素基因重组腺病毒诱导肝癌细胞凋亡的作用[J]. 中华肝脏病杂志, 2004,12(8):453-455
Li B, Ling CQ, Zhang C . et al. Induced apoptosis of recombinant adenovirus carrying melittin gene for hepatocellular carcinoma cell[J]. Zhonghua Gan Zang Bing Za Zhi, 2004,12(8):453-455
[3] 陈永强, 朱振安, 郝永强 , 等. 蜂毒素诱导骨肉瘤细胞U2OS凋亡与坏死的实验研究[J]. 中西医结合学报, 2004,2(3):208-209
Chen YQ, Zhu ZA, Hao YQ . et al. Effect of melittin on apoptsis and necrosis of U2OS cells[J]. Zhong Xi Yi Jie He Xue Bao, 2004,2(3):208-209
[4] Itoh N, Yonehara S, Ishii A , et al. The polypeptide encoded by cDNA for human cell surface antigen Fas can mediate apoptosis[J]. Cell, 1991,66(2):233-243
doi: 10.1016/0092-8674(91)90614-5 pmid: 1713127
[5] Houghton JA, Harwood FG , Tillman DM.Thymineless death in colon carcinoma cells is mediated via Fas signaling[J].Proc Natl Acad Sci U S A, 1997, 94(): 8144-8149
[6] 刘岭, 凌昌全, 黄雪强 . 蜂毒素的纯化方法及体外抗肿瘤研究[J]. 中国生化药物杂志, 2003,24(4):163-166
Liu L, Ling CQ, Huang XQ . Study on purification of melittin and its effect on anti-tumor in vitro[J]. Zhongguo Sheng Hua Yao Wu Za Zhi, 2003,24(4):163-166
[7] 张晨, 凌昌全, 李柏 , 等. 蜂毒素对肝癌细胞系SMMC7721增殖的影响[J]. 中草药, 2003,34(1):43-45
Zhang C, Ling CQ, Li B . Effect of melittin on proliferation of hepatocarcinoma cell line SMMC7721[J]. Zhong Cao Yao, 2003,34(1):43-45
[8] 凌昌全, 李柏, 张晨 , 等. 蜂毒素基因重组腺病毒体内外抗肝癌作用实验[J]. 中华肝脏病杂志, 2004,12(12):741-744
Ling CQ, Li B, Zhang C , et al. Anti-hepatocarcinoma effect of recombinant adenovirus carrying melittin gene[J]. Zhonghua Gan Zang Bing Za Zhi, 2004,12(12):741-744
[9] Ling CQ, Li B, Zhang C , et al. Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma[J]. Ann Oncol, 2005,16(1):109-115
doi: 10.1093/annonc/mdi019 pmid: 15598947
[10] Zhang C, Ao Z, Seth A , et al. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells[J]. J Immunol, 1996,157(9):3980-3987
[11] Koester SK, Roth P, Mikulka WR , et al. Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7[J]. Cytometry, 1997,29(4):306-312
[12] 顾伟, 韩克起, 苏永华 , 等. 蟾毒灵对裸鼠人肝癌移植瘤的抑制作用及对Bcl-2和Bax蛋白表达的影响[J]. 中西医结合学报, 2007,5(2):155-159
Gu W, Han KQ, Su YH , et al. Inhibition action of bufalin on human transplanted hepatocellular tumor and its effects on expressions of Bcl-2 and Bax proteins in nude mice[J]. Zhong Xi Yi Jie He Xue Bao, 2007,5(2):155-159
[13] Métivier D, Dallaporta B, Zamzami N , et al. Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific fluorochromes[J]. Immunol Lett, 1998,61(2-3):157-163
[14] Suda T, Okazaki T, Naito Y , et al. Expression of the ligand in cells of T cell lineage[J]. J Immunol, 1995,154(8):3806-3813
doi: 10.3357/ASEM.21011.2010 pmid: 7706720
[1] Gai Ran, Xi-lin Feng, Yi-lin Xie, Qing-yun Zheng, Peng-peng Guo, Ming Yang, Ying-lu Feng, Chen Ling, Li-qing Zhu, Chen Zhong. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy. Journal of Integrative Medicine, 2021, 19(6): 515-525.
[2] Hao Gou, Ruo-chen Huang, Yong-hua Su, Wei Li. Design of dual targeting immunomicelles loaded with bufalin and study of their anti-tumor effect on liver cancer. Journal of Integrative Medicine, 2021, 19(5): 408-417.
[3] Liang Ding, Xin-you Zhang, Di-yao Wu, Meng-ling Liu. Application of an extreme learning machine network with particle swarm optimization in syndrome classification of primary liver cancer. Journal of Integrative Medicine, 2021, 19(5): 395-407.
[4] Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248.
[5] Huo-jun Zhang, Ji-jin Yang, Wei-xing Wang, Xu Jiang, Yan-jun Mao, Chao-ai Yang, Ji-xiang Guo. Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy. Journal of Chinese Integrative Medicine, 2008, 6(9): 907-910.
[6] Zhi-qiang Pan, Zhao-qin Fang, Wen-li Lu, Chao Liang, Zhong-hua Wu, Xiao-mei Liu, Li Hou, Hui Zhang, Shao-yuan Zhuo, Ming-juan Liao, Bi-feng Gao. Differentially expressed genes in adrenal gland of H22 liver cancer mice with different syndromes and in different stages. Journal of Chinese Integrative Medicine, 2008, 6(8): 843-851.
[7] Zhi-jun Dai, Xi-jing Wang, Qian Xue, Zong-zheng Ji, Xiao-xu Liu, Hua-feng Kang, Hai-tao Guan, Xiao-bin Ma, Hong-tao Ren. Effects of Scutellaria Barbata drug-containing serum on apoptosis and mitochondrial transmembrane potential of hepatoma H22 cells. Journal of Chinese Integrative Medicine, 2008, 6(8): 821-826.
[8] Zhi-jun Dai, Xi-jing Wang, Zong-zheng Ji, Zong-fang Li, Wei Tang, Hua-feng Kang, Xiao-bin Ma, Lei Liu. Scutellaria barbata extract enhances efficacy and reduces toxicity of chemotherapy in hepatoma H22-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(7): 720-724.
[9] Hong-yun Chen, Zhe Chen. Transcatheter arterial chemoembolization combined with other therapies for the treatment of primary hepatic carcinoma: a review. Journal of Chinese Integrative Medicine, 2008, 6(4): 422-426.
[10] Hai-bo Yu, Cheng-en Pan, Wu-jun Wu, Si-hai Zhao, Hui-feng Zhang. Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells. Journal of Chinese Integrative Medicine, 2008, 6(3): 270-273.
[11] Zhen Sun, Yong-hua Su, Xiao-qiang Yue. Professor Ling Changquan's experience in treating primary liver cancer: an analysis of herbal medication. Journal of Chinese Integrative Medicine, 2008, 6(12): 1221-1225.
[12] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82.
[13] Xiao-yan Mu, Ai-guang Zhao. Progress in research of traditional Chinese medicine in inducing differentiation of human hepatoma cells. Journal of Chinese Integrative Medicine, 2007, 5(1): 92-96.
[14] Ying-lu Feng, Chang-quan Ling, De-zeng Zhu, Chao-qin Yu, Zhe Chen, Bai Li. Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: A randomized, controlled and double-blinded prospective trial. Journal of Chinese Integrative Medicine, 2005, 3(2): 99-102.
[15] Chang-quan Ling, Qing Liu, Dong-tao Li, Xiao-qiang Yue, Feng-gang Hou, De-zeng Zhu, Chao-qin Yu, Zhe Chen, Xiao-feng Zhai, Yang Yu. Study of a qualitative diagnostic criterion for basic syndromes of traditional Chinese medicine in patients with primary liver cancer. Journal of Chinese Integrative Medicine, 2005, 3(2): 95-98.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228